Hyper Lab Blog

At the Drug Discovery Conference (DDC) 2024 and American Association of Cancer Research (AACR) 2024, held in April 2024, HITS unveiled Hyper Lab to the world. In this post, we will introduce a research scenario to demonstrate the use cases of Hyper Lab.

In this article, we analyze the posters submitted to DDC 2024, categorized by country, organization, and topic.

Summarize the drug discovery sessions that will be presented at AACR 2024.

We've summarized three important papers for AI drug discovery. These papers will help you understand the fundamentals of AI drug discovery and move forward with the latest research.

We've covered things to consider when defining a binding site during structure-based drug discovery research (SBDD).

Let's take a look at the trends in drug discovery papers accepted at ICLR 2024.

What's the biggest change in AlphaFold-latest compared to the last publicly available model, AlphaFold 2.3?

An analysis of global pharma M&A in 2023 shows that the post-pandemic market is poised for a revitalization.

What did we see at NeurIPS 2023 about the future of drug discovery?

This article introduces the status of new drug approvals in Korea and the FDA from the past to the present. In Korea, 36 new drugs have been approved, and in the FDA, 30 new drugs have been approved recently.